As illustrated in Fig. 4A and B, treatment of the rhabdomyosarcoma RD cells with B-RAF inhibitor PLX-4720 was followed by a statistically significant decrease in hERG cell membrane protein abundance as compared to rhabdomyosarcoma RD cells treated with vehicle alone. This evidence concerns the gene RAF1 and rhabdomyosarcoma.